GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,362,000 | -12.6% | 31,293 | -12.6% | 0.38% | -1.3% |
| Q1 2022 | $1,559,000 | -6.5% | 35,793 | -5.3% | 0.39% | -11.9% |
| Q4 2021 | $1,667,000 | +5.1% | 37,793 | -8.9% | 0.44% | +6.8% |
| Q3 2021 | $1,586,000 | -6.3% | 41,500 | -2.4% | 0.41% | -5.1% |
| Q2 2021 | $1,692,000 | +9.0% | 42,500 | -2.3% | 0.43% | +2.9% |
| Q1 2021 | $1,553,000 | -10.4% | 43,500 | -7.6% | 0.42% | -26.2% |
| Q4 2020 | $1,733,000 | +5.9% | 47,100 | +8.3% | 0.57% | -5.8% |
| Q3 2020 | $1,637,000 | -77.2% | 43,500 | -75.3% | 0.60% | -58.9% |
| Q2 2020 | $7,183,000 | +0.3% | 176,100 | -6.9% | 1.47% | +11.9% |
| Q1 2020 | $7,165,000 | -19.4% | 189,100 | 0.0% | 1.32% | +12.9% |
| Q4 2019 | $8,886,000 | -8.0% | 189,100 | -16.5% | 1.16% | -2.6% |
| Q3 2019 | $9,663,000 | -3.6% | 226,400 | -9.6% | 1.20% | +0.4% |
| Q2 2019 | $10,021,000 | -20.2% | 250,400 | -16.7% | 1.19% | -10.5% |
| Q1 2019 | $12,558,000 | – | 300,500 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |